Rydapt Capsules 25mg
Couldn't load pickup availability
You can promote by sharing on social networks on the links.
Product Description
Rydapt Capsules 25mg is a prescription anticancer medication used for certain blood cancers. It is a targeted therapy that works by blocking abnormal proteins responsible for cancer cell growth, helping slow disease progression in specific leukemia and mast cell disorders. It is used under strict oncology supervision.
Product Overview
Product Name: Rydapt Capsules 25mg
Generic Name: Midostaurin
Form: Oral capsules
Strength: 25mg
Pack Size: Varies by manufacturer
Manufactured By: Novartis / licensed manufacturers
Used For: FLT3-positive acute myeloid leukemia (AML), systemic mastocytosis (as prescribed)
Prescription Required: Yes
Ingredients & How They Work
Midostaurin is a multi-kinase inhibitor that blocks FLT3 and other signaling pathways involved in abnormal cancer cell growth. This reduces proliferation of malignant blood cells and supports disease control.
Key Benefits
- Targets FLT3-positive AML
- Helps control aggressive blood cancers
- Used in combination chemotherapy
- Blocks cancer cell signaling pathways
- Supports improved treatment outcomes in selected patients
How to Use
Taken orally as prescribed by an oncologist, usually with food. Dosage depends on condition and treatment plan. Not for self-use.
Side Effects & Precautions
Common effects include nausea, vomiting, diarrhea, fatigue, fever, and low blood counts. Serious risks include infections, liver toxicity, and heart rhythm changes. Regular monitoring is required.
Storage Instructions
Store at room temperature in a dry place away from moisture and heat. Keep in original packaging.
Important Note
Rydapt Capsules 25mg must only be used under oncologist supervision with regular blood and organ monitoring.